Wuhan Hiteck Biological Pharma Co.,Ltd
SZSE:300683.SZ
46.4 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 150.781 | 131.888 | 163.855 | 151.979 | 147.814 | 138.635 | 141.987 | 159.407 | 221.027 | 166.205 | 222.313 | 166.826 | 67.716 | 157.828 | 175.529 | 156.254 | 127.648 | 64.692 | 149.64 | 151.633 | 162.582 | 156.309 | 178.822 | 143.469 | 136.832 | 131.75 | 173.265 | 188.294 | 218.75 | 169.882 | 249.419 | 189.163 | 182.918 | 149.475 |
| Cost of Revenue
| 86.417 | 79.251 | 100.325 | 80.048 | 86.735 | 77.947 | 68.921 | 81.995 | 120.664 | 83.302 | 128.907 | 65.647 | -3.873 | 74.109 | 80.116 | 59.893 | 60.671 | 13.402 | 46.697 | 34.452 | 20.417 | 18.692 | 20.213 | 8.889 | 7.904 | 7.159 | 8.898 | 8.17 | 9.573 | 8.504 | 11.489 | 9.891 | 14.212 | 0 |
| Gross Profit
| 64.364 | 52.636 | 63.53 | 71.931 | 61.08 | 60.689 | 73.066 | 77.412 | 100.363 | 82.903 | 93.406 | 101.179 | 71.589 | 83.719 | 95.413 | 96.361 | 66.977 | 51.29 | 102.943 | 117.18 | 142.164 | 137.617 | 158.609 | 134.58 | 128.928 | 124.591 | 164.368 | 180.124 | 209.176 | 161.378 | 237.93 | 179.272 | 168.706 | 149.475 |
| Gross Profit Ratio
| 0.427 | 0.399 | 0.388 | 0.473 | 0.413 | 0.438 | 0.515 | 0.486 | 0.454 | 0.499 | 0.42 | 0.606 | 1.057 | 0.53 | 0.544 | 0.617 | 0.525 | 0.793 | 0.688 | 0.773 | 0.874 | 0.88 | 0.887 | 0.938 | 0.942 | 0.946 | 0.949 | 0.957 | 0.956 | 0.95 | 0.954 | 0.948 | 0.922 | 1 |
| Reseach & Development Expenses
| 28.748 | 27.938 | 38.164 | 39.606 | 26.938 | 24.195 | 35.959 | 27.783 | 27.931 | 29.76 | 30.235 | 30.156 | 23.081 | 19.695 | 31.984 | 19.318 | 24.206 | 10.614 | 20.558 | 15.175 | 15.92 | 10.996 | 11.303 | 9.737 | 8.655 | 0 | 32.361 | 5.89 | 10.071 | 0 | 30.035 | 0 | 6.709 | 0 |
| General & Administrative Expenses
| -31.188 | 49.435 | -36.639 | 58.506 | -8.442 | 23.018 | -35.994 | 23.23 | -4.813 | 19.864 | -25.386 | 47.165 | -0.053 | 20.238 | -12.907 | 22.072 | 0.41 | 14.921 | -13.931 | 16.194 | 0.038 | 11.503 | -2.002 | 8.587 | -4.562 | 10.044 | -20.563 | 12.188 | -3.834 | 9.965 | -19.661 | 12.882 | 16.359 | 0 |
| Selling & Marketing Expenses
| 36.27 | 27.79 | 29.341 | 31.798 | 36.13 | 31.396 | 29.928 | 37.564 | 28.323 | 30.89 | 42.647 | 37.756 | 31.922 | 33.34 | 36.743 | 52.629 | 35.697 | 26.723 | 62.392 | 78.807 | 92.061 | 77.811 | 108.089 | 90.433 | 77.739 | 89.406 | 107.128 | 120.558 | 151.112 | 117.088 | 154.238 | 123.639 | 230.697 | 0 |
| SG&A
| 39.744 | 77.226 | -7.298 | 90.303 | 27.688 | 54.414 | -6.066 | 60.795 | 23.509 | 50.754 | 17.261 | 84.921 | 31.869 | 53.578 | 23.836 | 74.701 | 36.107 | 41.643 | 48.461 | 95.001 | 92.099 | 89.314 | 106.087 | 99.02 | 73.177 | 99.449 | 86.565 | 132.746 | 147.277 | 127.052 | 134.578 | 136.521 | 248.292 | 0 |
| Other Expenses
| -19.117 | -0.556 | -2.814 | -4.166 | -1.669 | -0.265 | -0.436 | -0.172 | -3.113 | 2.72 | -0.528 | 0.113 | -0.333 | -0.136 | -13.835 | -0.133 | -5.088 | -0.072 | -8.554 | -0.16 | -1.647 | -1.2 | -0.426 | 0.019 | 0.45 | -0.235 | 8.014 | 0.557 | 0.388 | 0.428 | 1.096 | 0.15 | -128.271 | -118.79 |
| Operating Expenses
| 87.608 | 105.039 | 104.744 | 95.296 | 85.928 | 77.602 | 90.537 | 87.479 | 81.318 | 79.095 | 101.237 | 88.833 | 79.29 | 72.108 | 105.368 | 93.973 | 75.077 | 51.829 | 113.996 | 109.844 | 120.599 | 100.951 | 132.709 | 109.282 | 88.026 | 100.017 | 120.012 | 133.679 | 162.704 | 127.918 | 174.561 | 137.122 | -128.271 | -118.79 |
| Operating Income
| -23.244 | -27.891 | -99.999 | -20.289 | -16.234 | -6.55 | -28.556 | -4.973 | 20.889 | 5.817 | 8.591 | 11.315 | -16.656 | 18.09 | -26.173 | -5.964 | -6.941 | 4.003 | -8.73 | 11.278 | 36.488 | 36.015 | 19.601 | 32.146 | 25.795 | 27.704 | 32.111 | 44.385 | 44.503 | 35.455 | 69.155 | 41.614 | 40.435 | 30.685 |
| Operating Income Ratio
| -0.154 | -0.211 | -0.61 | -0.133 | -0.11 | -0.047 | -0.201 | -0.031 | 0.095 | 0.035 | 0.039 | 0.068 | -0.246 | 0.115 | -0.149 | -0.038 | -0.054 | 0.062 | -0.058 | 0.074 | 0.224 | 0.23 | 0.11 | 0.224 | 0.189 | 0.21 | 0.185 | 0.236 | 0.203 | 0.209 | 0.277 | 0.22 | 0.221 | 0.205 |
| Total Other Income Expenses Net
| 22.22 | -0.556 | -2.814 | -4.166 | -1.669 | -0.265 | -0.436 | -0.172 | -3.113 | 2.72 | -0.528 | 0.113 | -0.333 | -0.136 | -2.102 | -0.133 | 0.014 | -0.072 | -0.231 | -0.16 | -0.849 | -1.2 | -0.426 | 0.019 | 0.45 | -0.235 | 8.014 | 0.557 | 0.388 | 0.428 | 1.09 | 0.15 | 0.607 | 0.348 |
| Income Before Tax
| -1.024 | -28.446 | -102.813 | -24.455 | -17.903 | -6.815 | -28.992 | -5.146 | 17.776 | 8.538 | 8.063 | 11.427 | -16.989 | 17.955 | -28.275 | -6.097 | -6.927 | 3.931 | -8.961 | 11.118 | 35.639 | 34.815 | 19.175 | 32.165 | 26.244 | 27.469 | 40.125 | 44.942 | 44.89 | 35.883 | 70.245 | 41.764 | 41.042 | 31.033 |
| Income Before Tax Ratio
| -0.007 | -0.216 | -0.627 | -0.161 | -0.121 | -0.049 | -0.204 | -0.032 | 0.08 | 0.051 | 0.036 | 0.068 | -0.251 | 0.114 | -0.161 | -0.039 | -0.054 | 0.061 | -0.06 | 0.073 | 0.219 | 0.223 | 0.107 | 0.224 | 0.192 | 0.208 | 0.232 | 0.239 | 0.205 | 0.211 | 0.282 | 0.221 | 0.224 | 0.208 |
| Income Tax Expense
| 5.924 | -10.954 | -4.186 | -7.656 | -6.801 | -5.1 | 3.606 | -4.586 | 2.607 | -1.553 | -2.893 | -1.737 | -8.718 | 3.788 | -13.74 | 0.769 | 1.398 | -0.122 | -3.263 | -0.906 | 10.051 | 5.541 | 2.236 | 3.07 | 3.903 | 4.379 | 6.69 | 6.055 | 6.53 | 5.368 | 11.141 | 5.593 | 6.031 | 4.571 |
| Net Income
| -6.22 | -16.546 | -94.383 | -15.312 | -9.656 | -1.472 | -32.852 | -0.05 | 11.182 | 7.691 | 9.018 | 11.419 | -7.312 | 14.529 | -14.499 | -6.747 | -8.03 | 4.251 | -5.094 | 12.323 | 25.951 | 29.855 | 18.152 | 29.52 | 22.722 | 23.743 | 33.726 | 39.125 | 38.649 | 30.89 | 59.394 | 36.186 | 35.011 | 26.462 |
| Net Income Ratio
| -0.041 | -0.125 | -0.576 | -0.101 | -0.065 | -0.011 | -0.231 | -0 | 0.051 | 0.046 | 0.041 | 0.068 | -0.108 | 0.092 | -0.083 | -0.043 | -0.063 | 0.066 | -0.034 | 0.081 | 0.16 | 0.191 | 0.102 | 0.206 | 0.166 | 0.18 | 0.195 | 0.208 | 0.177 | 0.182 | 0.238 | 0.191 | 0.191 | 0.177 |
| EPS
| -0.048 | -0.13 | -0.72 | -0.12 | -0.074 | -0.011 | -0.27 | -0 | 0.092 | 0.063 | 0.074 | 0.11 | -0.071 | 0.14 | -0.14 | -0.07 | -0.097 | 0.04 | -0.049 | 0.12 | 0.25 | 0.29 | 0.17 | 0.29 | 0.22 | 0.23 | 0.97 | 0.38 | 0.5 | 0.4 | 0.77 | 0.47 | 0.45 | 0.34 |
| EPS Diluted
| -0.048 | -0.13 | -0.72 | -0.12 | -0.074 | -0.011 | -0.27 | -0 | 0.092 | 0.06 | 0.074 | 0.11 | -0.071 | 0.14 | -0.14 | -0.07 | -0.097 | 0.04 | -0.049 | 0.12 | 0.25 | 0.29 | 0.17 | 0.29 | 0.22 | 0.23 | 0.97 | 0.38 | 0.5 | 0.4 | 0.77 | 0.47 | 0.45 | 0.34 |
| EBITDA
| -0.039 | -51.288 | -29.261 | -25.087 | -22.164 | -13.524 | -9.867 | -8.176 | 30.263 | 5.349 | -0.591 | 16.679 | 0.943 | 17.888 | -15.823 | 16.806 | 3.398 | 5.857 | 10.946 | 12.937 | 21.859 | 43.257 | 25.54 | 32.367 | 65.906 | 26.053 | 63.083 | 51.422 | -89.95 | 169.882 | 64.276 | 42.496 | -80.146 | 149.475 |
| EBITDA Ratio
| -0 | -0.389 | -0.179 | -0.165 | -0.15 | -0.098 | -0.069 | -0.051 | 0.137 | 0.032 | -0.003 | 0.1 | 0.014 | 0.113 | -0.09 | 0.108 | 0.027 | 0.091 | 0.073 | 0.085 | 0.134 | 0.277 | 0.143 | 0.226 | 0.482 | 0.198 | 0.364 | 0.273 | -0.411 | 1 | 0.258 | 0.225 | -0.438 | 1 |